The FDA has declared that the shortage of popular weight-loss drugs, including Ozempic and Wegovy, is officially over.
The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.
A shortage of Danish drugmaker Novo Nordisk's popular weight-loss and diabetes drugs, Wegovy and Ozempic, has been resolved, ...
USA TODAY on MSN10d
Generic Wegovy, Ozempic compounds may become harder to get as FDA removes drug from shortage listAll doses of Ozempic and Wegovy were listed as available on the FDA's website in October, but the treatments had not been ...
USA TODAY on MSN10d
Shortage of popular drugs Wegovy and Ozempic is over, FDA says.The FDA said the shortage of Novo Nordisk's weight-loss drugs Wegovy and Ozempic is resolved. The move could limit cheaper compounded versions ...
The Associated Press on MSN6d
Patients struggle with lack of consistent coverage for popular weight-loss drugsMany employers and insurers are scaling back coverage of Wegovy and Zepbound and a key government program, Medicare, doesn’t ...
the active ingredient in Ozempic and Wegovy. Shares of Hims & Hers plunged 17% in mid-morning trading after the FDA's announcement. The FDA said it won't take enforcement action against ...
Feb 21 (Reuters) - The U.S. Food and Drug Administration said on Friday there was no longer a shortage of Novo Nordisk's NOVOb.CO popular weight-loss and diabetes drugs, Wegovy and ...
The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022. The FDA's announcement comes months after drugmaker Novo Nordisk told the agency ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback